[15,20–22] In areas with a higher incidence of TB, such as in Asian countries, a nearly 26-fold greater risk of TB was found in those exposed to TNF inhibitors agents.[23] In patients given infliximab, risk could be up to 30 times greater than in the general population.[24,25]. This evidence concerns the gene TNF and tuberculosis.